Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
August-2016 Volume 36 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2016 Volume 36 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)

  • Authors:
    • Lino Del Pup
    • Alberto Mantovani
    • Carla Cavaliere
    • Gaetano Facchini
    • Amalia Luce
    • Pasquale Sperlongano
    • Michele Caraglia
    • Massimiliano Berretta
  • View Affiliations / Copyright

    Affiliations: Division of Gynecological Oncology, CRO Aviano, National Cancer Institute, I-33081 Aviano, Italy, National Institute of Health, I-00161 Rome, Italy, Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori ‘Fondazione G. Pascale’ - IRCCS, I-80131 Naples, Italy, Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, I-80138 Naples, Italy, Unit of General and Geriatric Surgery, School of Medicine, Second University of Naples, I-80137 Naples, Italy, Department of Medical Oncology, CRO Aviano, National Cancer Institute, I-33081 Aviano, Italy
    Copyright: © Del Pup et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 603-612
    |
    Published online on: June 21, 2016
       https://doi.org/10.3892/or.2016.4886
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Endocrine disruptors (EDs) are pollutants that alter the endocrine system and are involved in carcinogenesis. EDs have multiple and complex levels of action. They can affect the synthesis, release and transport of natural hormones. In target tissues, EDs can reduce or increase the effects of natural hormones on their receptors and change signaling cascades. When ED exposure happens at critical periods of life, from embryo to puberty, they can act at doses considered safe for an adult. Furthermore, their epigenetic effects can also influence the cancer risk of future generations. The cancer mechanisms of known EDs are hereby reviewed, There are thousands of newly introduced substances whose potential endocrine-disrupting and cancer effects are completely unknown. Although there are still gaps in our knowledge, these data support the urgent need for health and environmental policies aimed at protecting the public and in particular, the developing fetus and women of reproductive age.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Macon MB and Fenton SE: Endocrine disruptors and the breast: Early life effects and later life disease. J Mammary Gland Biol Neoplasia. 18:43–61. 2013. View Article : Google Scholar : PubMed/NCBI

2 

US Environmental Protection Agency: Endocrine Disruptors Research.

3 

Maqbool F, Mostafalou S, Bahadar H and Abdollahi M: Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms. Life Sci. 145:265–273. 2016. View Article : Google Scholar

4 

Soto AM and Sonnenschein C: Environmental causes of cancer: Endocrine disruptors as carcinogens. Nat Rev Endocrinol. 6:363–370. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Hilakivi-Clarke L, de Assis S and Warri A: Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk. J Mammary Gland Biol Neoplasia. 18:25–42. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Caserta D, Maranghi L, Mantovani A, Marci R, Maranghi F and Moscarini M: Impact of endocrine disruptor chemicals in gynaecology. Hum Reprod Update. 14:59–72. 2008. View Article : Google Scholar

7 

Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP and Rudel RA: Environmental pollutants and breast cancer: Epidemiologic studies. Cancer. 109(Suppl 12): 2667–2711. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Collins LL, Lew BJ and Lawrence BP: TCDD exposure disrupts mammary epithelial cell differentiation and function. Reprod Toxicol. 28:11–17. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Warner M, Eskenazi B, Mocarelli P, Gerthoux PM, Samuels S, Needham L, Patterson D and Brambilla P: Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environ Health Perspect. 110:625–628. 2002. View Article : Google Scholar : PubMed/NCBI

10 

Bertazzi A, Pesatori AC, Consonni D, Tironi A, Landi MT and Zocchetti C: Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. Epidemiology. 4:398–406. 1993. View Article : Google Scholar : PubMed/NCBI

11 

Pesatori AC, Consonni D, Bachetti S, Zocchetti C, Bonzini M, Baccarelli A and Bertazzi PA: Short- and long-term morbidity and mortality in the population exposed to dioxin after the 'Seveso accident'. Ind Health. 41:127–138. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Laden F, Collman G, Iwamoto K, Alberg AJ, Berkowitz GS, Freudenheim JL, Hankinson SE, Helzlsouer KJ, Holford TR, Huang HY, et al: 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: Combined analysis of five U.S. studies. J Natl Cancer Inst. 93:768–776. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Wolff MS, Toniolo PG, Lee EW, Rivera M and Dubin N: Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst. 85:648–652. 1993. View Article : Google Scholar : PubMed/NCBI

14 

Hardell L, van Bavel B, Lindström G, Björnfoth H, Orgum P, Carlberg M, Sörensen CS and Graflund M: Adipose tissue concentrations of p,p′-DDE and the risk for endometrial cancer. Gynecol Oncol. 95:706–711. 2004. View Article : Google Scholar : PubMed/NCBI

15 

Pavuk M, Cerhan JR, Lynch CF, Kocan A, Petrik J and Chovancova J: Case-control study of PCBs, other organo-chlorines and breast cancer in Eastern Slovakia. J Expo Anal Environ Epidemiol. 13:267–275. 2003. View Article : Google Scholar : PubMed/NCBI

16 

Calle EE, Frumkin H, Henley SJ, Savitz DA and Thun MJ: Organochlorines and breast cancer risk. CA Cancer J Clin. 52:301–309. 2002. View Article : Google Scholar : PubMed/NCBI

17 

López-Cervantes M, Torres-Sánchez L, Tobías A and López-Carrillo L: Dichlorodiphenyldichloroethane burden and breast cancer risk: A meta-analysis of the epidemiologic evidence. Environ Health Perspect. 112:207–214. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Ibarluzea JmJ, Fernández MF, Santa-Marina L, Olea-Serrano MF, Rivas AM, Aurrekoetxea JJ, Expósito J, Lorenzo M, Torné P, Villalobos M, et al: Breast cancer risk and the combined effect of environmental estrogens. Cancer Causes Control. 15:591–600. 2004. View Article : Google Scholar

19 

Cassidy RA, Natarajan S and Vaughan GM: The link between the insecticide heptachlor epoxide, estradiol, and breast cancer. Breast Cancer Res Treat. 90:55–64. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Charlier C, Albert A, Herman P, Hamoir E, Gaspard U, Meurisse M and Plomteux G: Breast cancer and serum organochlorine residues. Occup Environ Med. 60:348–351. 2003. View Article : Google Scholar : PubMed/NCBI

21 

Engel LS, Hill DA, Hoppin JA, Lubin JH, Lynch CF, Pierce J, Samanic C, Sandler DP, Blair A and Alavanja MC: Pesticide use and breast cancer risk among farmers' wives in the agricultural health study. Am J Epidemiol. 161:121–135. 2005. View Article : Google Scholar : PubMed/NCBI

22 

Cohn BA, Wolff MS, Cirillo PM and Sholtz RI: DDT and breast cancer in young women: New data on the significance of age at exposure. Environ Health Perspect. 115:1406–1414. 2007.PubMed/NCBI

23 

Ingber SZ, Buser MC, Pohl HR, Abadin HG, Murray HE and Scinicariello F: DDT/DDE and breast cancer: A meta-analysis. Regul Toxicol Pharmacol. 67:421–433. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Tiemann U: In vivo and in vitro effects of the organochlorine pesticides DDT, TCPM, methoxychlor, and lindane on the female reproductive tract of mammals: A review. Reprod Toxicol. 25:316–326. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Gore AC, Walker DM, Zama AM, Armenti AE and Uzumcu M: Early life exposure to endocrine-disrupting chemicals causes lifelong molecular reprogramming of the hypothalamus and premature reproductive aging. Mol Endocrinol. 25:2157–2168. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Wetzel LT, Luempert LG III, Breckenridge CB, Tisdel MO, Stevens JT, Thakur AK, Extrom PJ and Eldridge JC: Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley and Fischer 344 rats. J Toxicol Environ Health. 43:169–182. 1994. View Article : Google Scholar : PubMed/NCBI

27 

Young HA, Mills PK, Riordan DG and Cress RD: Triazine herbicides and epithelial ovarian cancer risk in central California. J Occup Environ Med. 47:1148–1156. 2005. View Article : Google Scholar : PubMed/NCBI

28 

Ventura C, Nieto MR, Bourguignon N, Lux-Lantos V, Rodriguez H, Cao G, Randi A, Cocca C and Núñez M: Pesticide chlorpyrifos acts as an endocrine disruptor in adult rats causing changes in mammary gland and hormonal balance. J Steroid Biochem Mol Biol. 156:1–9. 2016. View Article : Google Scholar

29 

Teitelbaum SL, Gammon MD, Britton JA, Neugut AI, Levin B and Stellman SD: Reported residential pesticide use and breast cancer risk on Long Island, New York. Am J Epidemiol. 165:643–651. 2007. View Article : Google Scholar

30 

Alavanja MC, Sandler DP, Lynch CF, Knott C, Lubin JH, Tarone R, Thomas K, Dosemeci M, Barker J, Hoppin JA, et al: Cancer incidence in the agricultural health study. Scand J Work Environ Health. 31(Suppl 1): 39–45; discussion 5–7. 2005.PubMed/NCBI

31 

Thongprakaisang S, Thiantanawat A, Rangkadilok N, Suriyo T and Satayavivad J: Glyphosate induces human breast cancer cells growth via estrogen receptors. Food Chem Toxicol. 59:129–136. 2013. View Article : Google Scholar : PubMed/NCBI

32 

Pestana D, Teixeira D, Faria A, Domingues V, Monteiro R and Calhau C: Effects of environmental organochlorine pesticides on human breast cancer: Putative involvement on invasive cell ability. Environ Toxicol. 30:168–176. 2015. View Article : Google Scholar

33 

Lovekamp-Swan T and Davis BJ: Mechanisms of phthalate ester toxicity in the female reproductive system. Environ Health Perspect. 111:139–145. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Chen FP and Chien MH: Lower concentrations of phthalates induce proliferation in human breast cancer cells. Climacteric. 17:377–384. 2014. View Article : Google Scholar

35 

Hunt PA, Sathyanarayana S, Fowler PA and Trasande L: Female reproductive disorders, diseases, and costs of exposure to endocrine disrupting chemicals in the European Union. J Clin Endocrinol Metab. 101:1562–1570. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA and Weiss NS: Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control. 19:1357–1364. 2008. View Article : Google Scholar : PubMed/NCBI

37 

Johnson NP, Hummelshoj L, Abrao MS, Adamson GD, Allaire C, Amelung V, Andersson E, Becker C, Birna Ardal KB, Bush D, et al: World Endometriosis Society Montpellier Consortium: Consensus on current management of endometriosis. Hum Reprod. 28:1552–1568. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Roy D, Morgan M, Yoo C, Deoraj A, Roy S, Yadav VK, Garoub M, Assaggaf H and Doke M: Integrated bioinformatics, environmental epidemiologic and genomic approaches to identify environmental and molecular links between endometriosis and breast cancer. Int J Mol Sci. 16:25285–25322. 2015. View Article : Google Scholar : PubMed/NCBI

39 

European Food Safety Authority: Scientific opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA J. 13:39782015. View Article : Google Scholar

40 

Caserta D, Ciardo F, Bordi G, Guerranti C, Fanello E, Perra G, Borghini F, La Rocca C, Tait S, Bergamasco B, et al: Correlation of endocrine disrupting chemicals serum levels and white blood cells gene expression of nuclear receptors in a population of infertile women. Int J Endocrinol. 2013:5107032013. View Article : Google Scholar : PubMed/NCBI

41 

Hengstler JG, Foth H, Gebel T, Kramer P-J, Lilienblum W, Schweinfurth H, Völkel W, Wollin KM and Gundert-Remy U: Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol. 41:263–291. 2011. View Article : Google Scholar : PubMed/NCBI

42 

Soto AM, Brisken C, Schaeberle C and Sonnenschein C: Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors. J Mammary Gland Biol Neoplasia. 18:199–208. 2013. View Article : Google Scholar : PubMed/NCBI

43 

Durando M, Kass L, Piva J, Sonnenschein C, Soto AM, Luque EH and Muñoz-de-Toro M: Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect. 115:80–86. 2007. View Article : Google Scholar : PubMed/NCBI

44 

Murray TJ, Maffini MV, Ucci AA, Sonnenschein C and Soto AM: Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol. 23:383–390. 2007. View Article : Google Scholar :

45 

van der Ven LT, van de Kuil T, Leonards PE, Slob W, Lilienthal H, Litens S, Herlin M, Håkansson H, Cantón RF, van den Berg M, et al: Endocrine effects of hexabromocyclododecane (HBCD) in a one-generation reproduction study in Wistar rats. Toxicol Lett. 185:51–62. 2009. View Article : Google Scholar : PubMed/NCBI

46 

Jenkins S, Raghuraman N, Eltoum I, Carpenter M, Russo J and Lamartiniere CA: Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats. Environ Health Perspect. 117:910–915. 2009. View Article : Google Scholar : PubMed/NCBI

47 

Acevedo N, Davis B, Schaeberle CM, Sonnenschein C and Soto AM: Perinatally administered bisphenol a as a potential mammary gland carcinogen in rats. Environ Health Perspect. 121:1040–1046. 2013.PubMed/NCBI

48 

Dairkee SH, Seok J, Champion S, Sayeed A, Mindrinos M, Xiao W, Davis RW and Goodson WH: Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. Cancer Res. 68:2076–2080. 2008. View Article : Google Scholar : PubMed/NCBI

49 

Montes-Grajales D, Bernardes GJ and Olivero-Verbel J: Urban endocrine disruptors targeting breast cancer proteins. Chem Res Toxicol. 29:150–161. 2016. View Article : Google Scholar

50 

Swan SH: Intrauterine exposure to diethylstilbestrol: Long-term effects in humans. APMIS. 108:793–804. 2000. View Article : Google Scholar

51 

International Agency for Research on Cancer (IARC): Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. 72. Hormonal Contraception and Post-Menopausal Hormonal Therapy; Lyon: pp. 291–294. 1999

52 

Cook JD, Davis BJ, Goewey JA, Berry TD and Walker CL: Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats. Reprod Sci. 14:121–136. 2007. View Article : Google Scholar : PubMed/NCBI

53 

World Health Organization (WHO); International Agency for Research on Cancer (IARC): Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. 58. IARC; Lyon: 1993

54 

Liu Z, Yu X and Shaikh ZA: Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium. Toxicol Appl Pharmacol. 228:286–294. 2008. View Article : Google Scholar : PubMed/NCBI

55 

McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM and Newcomb PA: Cadmium exposure and breast cancer risk. J Natl Cancer Inst. 98:869–873. 2006. View Article : Google Scholar : PubMed/NCBI

56 

Akesson A, Julin B and Wolk A: Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: A population-based prospective cohort study. Cancer Res. 68:6435–6441. 2008. View Article : Google Scholar : PubMed/NCBI

57 

Julin B, Wolk A, Bergkvist L, Bottai M and Åkesson A: Dietary cadmium exposure and risk of postmenopausal breast cancer: A population-based prospective cohort study. Cancer Res. 72:1459–1466. 2012. View Article : Google Scholar : PubMed/NCBI

58 

Mohapatra P, Preet R, Das D, Satapathy SR, Siddharth S, Choudhuri T, Wyatt MD and Kundu CN: The contribution of heavy metals in cigarette smoke condensate to malignant transformation of breast epithelial cells and in vivo initiation of neoplasia through induction of a PI3K-AKT-NFκB cascade. Toxicol Appl Pharmacol. 274:168–179. 2014. View Article : Google Scholar

59 

Rahim F, Jalali A and Tangestani R: Breast cancer frequency and exposure to cadmium: A meta-analysis and systematic review. Asian Pac J Cancer Prev. 14:4283–4287. 2013. View Article : Google Scholar

60 

Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P, Greizerstein H, Marshall JR, Graham S and Ambrosone CB: Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 8:41–44. 1999.PubMed/NCBI

61 

Sergentanis TN and Economopoulos KP: Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: A meta-analysis. Breast Cancer Res Treat. 122:459–469. 2010. View Article : Google Scholar

62 

Cohn BA, Terry MB, Plumb M and Cirillo PM: Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 50. Breast Cancer Res Treat. 136:267–275. 2012. View Article : Google Scholar : PubMed/NCBI

63 

Bouker KB and Hilakivi-Clarke L: Genistein: Does it prevent or promote breast cancer? Environ Health Perspect. 108:701–708. 2000. View Article : Google Scholar : PubMed/NCBI

64 

Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, Ruan Z, Gao YT and Zheng W: Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev. 10:483–488. 2001.PubMed/NCBI

65 

Trock B, White BL, Clarke R and Hilakivi-Clarke L: Meta-analysis of soy intake and breast cancer risk. Third International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. J Nutr. 130:653S–680S. 2000.

66 

Messina MJ and Loprinzi CL: Soy for breast cancer survivors: A critical review of the literature. J Nutr. 131(Suppl 11): 3095S–3108S. 2001.PubMed/NCBI

67 

This P, De La Rochefordière A, Clough K, Fourquet A and Magdelenat H; Breast Cancer Group of the Institut Curie: Phytoestrogens after breast cancer. Endocr Relat Cancer. 8:129–134. 2001. View Article : Google Scholar : PubMed/NCBI

68 

Horn-Ross PL, John EM, Canchola AJ, Stewart SL and Lee MM: Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst. 95:1158–1164. 2003. View Article : Google Scholar : PubMed/NCBI

69 

Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S and Di Renzo GC: Endometrial effects of long-term treatment with phytoestrogens: A randomized, double-blind, placebo-controlled study. Fertil Steril. 82:145–148; quiz 265. 2004. View Article : Google Scholar : PubMed/NCBI

70 

Gaete L, Tchernitchin AN, Bustamante R, Villena J, Lemus I, Gidekel M, Cabrera G and Astorga P: Daidzein-estrogen interaction in the rat uterus and its effect on human breast cancer cell growth. J Med Food. 15:1081–1090. 2012. View Article : Google Scholar : PubMed/NCBI

71 

Greathouse KL, Bredfeldt T, Everitt JI, Lin K, Berry T, Kannan K, Mittelstadt ML, Ho SM and Walker CL: Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis. Mol Cancer Res. 10:546–557. 2012. View Article : Google Scholar : PubMed/NCBI

72 

Kang NH, Hwang KA, Lee HR, Choi DW and Choi KC: Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells. Food Chem Toxicol. 59:373–379. 2013. View Article : Google Scholar : PubMed/NCBI

73 

Reaves DK, Ginsburg E, Bang JJ and Fleming JM: Persistent organic pollutants and obesity: Are they potential mechanisms for breast cancer promotion? Endocr Relat Cancer. 22:R69–R86. 2015. View Article : Google Scholar : PubMed/NCBI

74 

Patterson AR, Mo X, Shapiro A, Wernke KE, Archer TK and Burd CJ: Sustained reprogramming of the estrogen response after chronic exposure to endocrine disruptors. Mol Endocrinol. 29:384–395. 2015. View Article : Google Scholar : PubMed/NCBI

75 

Burgio E and Migliore L: Towards a systemic paradigm in carcinogenesis: Linking epigenetics and genetics. Mol Biol Rep. 42:777–790. 2015. View Article : Google Scholar

76 

Berretta M, Di Francia R and Tirelli U: The new oncologic challenges in the 3RD millennium. WCRJ. 1:e1332014.

77 

Del Buono A, D'Orta A, Del Buono R, Del Buono MG, De Monaco A and Marullo MN: Relationship between diet and heavy metals in high risk of the environmental toxicity areas. Implication for cancer prevention. WCRJ. 1:e4112014.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Del Pup L, Mantovani A, Cavaliere C, Facchini G, Luce A, Sperlongano P, Caraglia M and Berretta M: Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review). Oncol Rep 36: 603-612, 2016.
APA
Del Pup, L., Mantovani, A., Cavaliere, C., Facchini, G., Luce, A., Sperlongano, P. ... Berretta, M. (2016). Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review). Oncology Reports, 36, 603-612. https://doi.org/10.3892/or.2016.4886
MLA
Del Pup, L., Mantovani, A., Cavaliere, C., Facchini, G., Luce, A., Sperlongano, P., Caraglia, M., Berretta, M."Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)". Oncology Reports 36.2 (2016): 603-612.
Chicago
Del Pup, L., Mantovani, A., Cavaliere, C., Facchini, G., Luce, A., Sperlongano, P., Caraglia, M., Berretta, M."Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)". Oncology Reports 36, no. 2 (2016): 603-612. https://doi.org/10.3892/or.2016.4886
Copy and paste a formatted citation
x
Spandidos Publications style
Del Pup L, Mantovani A, Cavaliere C, Facchini G, Luce A, Sperlongano P, Caraglia M and Berretta M: Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review). Oncol Rep 36: 603-612, 2016.
APA
Del Pup, L., Mantovani, A., Cavaliere, C., Facchini, G., Luce, A., Sperlongano, P. ... Berretta, M. (2016). Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review). Oncology Reports, 36, 603-612. https://doi.org/10.3892/or.2016.4886
MLA
Del Pup, L., Mantovani, A., Cavaliere, C., Facchini, G., Luce, A., Sperlongano, P., Caraglia, M., Berretta, M."Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)". Oncology Reports 36.2 (2016): 603-612.
Chicago
Del Pup, L., Mantovani, A., Cavaliere, C., Facchini, G., Luce, A., Sperlongano, P., Caraglia, M., Berretta, M."Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)". Oncology Reports 36, no. 2 (2016): 603-612. https://doi.org/10.3892/or.2016.4886
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team